Oncology

Article, Oncology / 21.06.2023

Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials

Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....

06/21/2023

Read Now

Article, Oncology / 13.02.2023

PCWG3 and Oncology Endpoints Webinar Summary PCWG3 and PSMA PET/CT Response Criteria

Learn more about the fundamentals of PCWG3 response criteria, PSMA PET/CT response criteria, data collection, and response assessment....

02/13/2023

Read Now

Article, Oncology / 15.12.2022

Fundamentals of iRECIST and Oncology Trial Endpoints MERIT Webinar Key Takeaways

Learn about the rules and principles of iRECIST, imaging endpoints, and special considerations for using iRECIST response criteria....

12/15/2022

Read Now

Oncology

Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials

PCWG3 and Oncology Endpoints Webinar Summary PCWG3 and PSMA PET/CT Response Criteria

Fundamentals of iRECIST and Oncology Trial Endpoints MERIT Webinar Key Takeaways

Let's Make Your
Project a Reality

Subscribe to our
Monthly eNewsletter

Oncology

Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials

PCWG3 and Oncology Endpoints Webinar Summary PCWG3 and PSMA PET/CT Response Criteria

Fundamentals of iRECIST and Oncology Trial Endpoints MERIT Webinar Key Takeaways

Let's Make Your Project a Reality

Subscribe to our Monthly eNewsletter

Let's Make Your
Project a Reality

Subscribe to our
Monthly eNewsletter